Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
SNP-318 by SciNeuro Pharmaceuticals for Alzheimer's Disease: Likelihood of Approval
SNP-318 is under clinical development by SciNeuro Pharmaceuticals and currently in Phase I for Alzheimer's Disease. According to GlobalData, Phase...
Data Insights
SNP-318 by SciNeuro Pharmaceuticals for Neurodegenerative Diseases: Likelihood of Approval
SNP-318 is under clinical development by SciNeuro Pharmaceuticals and currently in Phase I for Neurodegenerative Diseases. According to GlobalData, Phase...